Baker Kevin Paul 4
4 · FIVE PRIME THERAPEUTICS INC · Filed Sep 6, 2017
Insider Transaction Report
Form 4
Baker Kevin Paul
SVP, Development Sciences
Transactions
- Tax Payment
Common Stock
2017-09-01$34.34/sh−940$32,280→ 94,480 total
4 · FIVE PRIME THERAPEUTICS INC · Filed Sep 6, 2017
Common Stock